SCHEMBL7076729

SCHEMBL7076729

CCCC(=O)NS(=O)(=O)c1ccccc1NC(=O)c1ccccc1Oc1ccc2ccccc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1B P49286 2/20 0.45
RAB9A P51151 2/20 0.44
RAPGEF3 O95398 2/20 0.44
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
NPC1 O15118 1/20 0.42
PARG Q86W56 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
ALDH1A1 P00352 1/20 0.40
F2R P25116 1/20 0.40
TP53 P04637 1/20 0.40
PARP1 P09874 1/20 0.40
KAT6A Q92794 1/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
ATM Q13315 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7083339 0.88 CAPN1 (0.46) RAB9AMEN1KMT2ANPC1TP53
SCHEMBL7080643 0.83 RAB9A (0.43) MTNR1BRAB9AMEN1KMT2AL3MBTL1
SCHEMBL7083369 0.83 RAB9A (0.43) MTNR1BRAB9AMEN1KMT2AL3MBTL1
SCHEMBL7080256 0.83 HSD17B10 (0.50) MTNR1BRAB9AMEN1KMT2ANPC1
SCHEMBL7076725 0.82 MTNR1B (0.48) MTNR1BRAB9AMEN1KMT2ANPC1
SCHEMBL7080300 0.77 ALDH1A1 (0.48) MTNR1BRAB9AMEN1KMT2ANPC1
SCHEMBL7081568 0.76 PTK2 (0.41) L3MBTL1ALDH1A1MAPTNPSR1HSD17B10
SCHEMBL7077440 0.76 MAPT (0.41) MEN1KMT2AL3MBTL1ALDH1A1LMNA
SCHEMBL7080331 0.75 SGMS2 (0.52) MEN1KMT2A
SCHEMBL7744231 0.74 CASP1 (0.51) MTNR1BL3MBTL1ATMNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162818-A1 Acylsulfonamide derivative AJINOMOTO CO. INC. (JP) 2003-08-28 US disclosed
US-6555584-B1 Acetyl-coa carboxylase inhibitors AJINOMOTO CO., INC. (JP) 2003-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162818-A1 Acylsulfonamide derivative ACSS2, ACACA, FASN MTNR1B 980/4885RAB9A 3579/4885RAPGEF3 4803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.